Concepedia

Yongjun Li

YL

Statistics

Publications

5

Citations

152

H-Index

5

Active since

2017

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Yongjun Li is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, pharmaceutical formulation, and pharmacology.

ORCID

Publications per year

2017–2021

5

Publications

5

In Situ Characterization of Pharmaceutical Formulations by Dynamic Nuclear Polarization Enhanced MAS NMR

Qing Zhe Ni, Fengyuan Yang, Thach V. Can et al. · The Journal of Physical Chemistry B · 2017 · 67 citations · Full text

, , +11

Processing Impact on Performance of Solid Dispersions

Dan Zhang, Yung-Chi Lee, Zaher Shabani et al. · Pharmaceutics · 2018 · 32 citations · Full text

, , +17

The Development of Minitablets for a Pediatric Dosage Form for a Combination Therapy

Dan Zhang, Alfred C. F. Rumondor, Wei Zhu et al. · Journal of Pharmaceutical Sciences · 2020 · 20 citations

, , +14

Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation

Ashleigh N. Bristol, Matthew S. Lamm, Yongjun Li · Molecular Pharmaceutics · 2021 · 17 citations

, , +15

Mechanism and Impact of Excipient Incompatibility: Cross-Linking of Xanthan Gum in Pediatric Powder-for-Suspension Formulations

Yongjun Li, Dan Zhang, Jason T. Ash et al. · Journal of Pharmaceutical Sciences · 2019 · 16 citations

, , +15

1–5 of 5